- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06859047
The Echodynamic Approach (TECH)
March 17, 2025 updated by: Carlo Gaspardone, IRCCS Ospedale San Raffaele
Comprehensive Hemodynamic Assessment Via Echocardiography: the Echodynamic Approach Compared to Right Heart Catheterization
The aim of this prospective observational study is to assess the accuracy of non-invasive hemodynamic parameter estimation via trans-thoracic echocardiography (TTE) compared to the invasive gold standard of right heart catheterization (RHC).
This study will include patients who undergo both TTE and RHC on the same day, under the same hemodynamic conditions.
The primary research question is: how does the echodynamic evaluation perform compared to right heart catheterization?
Study Overview
Status
Recruiting
Detailed Description
The non-invasive echocardiographic assessment will be used to esimate via mathematic formulas all the direct and indirect paramethers obtained from the right side catheterization.
Each value obtained from the model using echocardiographic paramethers will be compared to the invasive finding.
Study Type
Observational
Enrollment (Estimated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Carlo Garspardone, Medical Doctor
- Phone Number: +393389920314
- Email: gaspardone.carlo@hsr.it
Study Locations
-
-
-
Bari, Italy
- Recruiting
- Ospedale Generale regionale "F.Miulli"
-
Contact:
- Fabrizio Fortunato
- Phone Number: +393489269237
- Email: fabrizio.fortunato1@gmail.com
-
Milan, Italy
- Recruiting
- IRCCS Ospedale San Raffaele
-
Contact:
- Carlo Gaspardone
- Phone Number: +393389920314
- Email: gaspardone.carlo@hsr.it
-
Pavia, Italy
- Recruiting
- IRCCS Policlinico San Matteo Pavia
-
Contact:
- Alessandro Fasolino
- Phone Number: +393385754572
- Email: alessandro.fasolino01@universitadipavia.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The study population consists of patients from multiple centers who received, within a short time frame (the same day), an invasive assessment of hemodynamic parameters through right heart catheterization and a non-invasive assessment through echocardiography.
Description
Inclusion Criteria:
- Clinical need for an invasive hemodynamic assessment and an echocardiographic evaluation on the same day
Exclusion Criteria:
- Incomplete hemodynamic assessment for any reason
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac output
Time Frame: Baseline
|
The primary outcome will be to compare the estimated value using echocardiographic parameters with the same invasive measurement by right heart catheterization recorded on the same day to avoid different cardiac load conditions.
Right heart catheterization will be from either femural or jugular vein approach.
The measure's unit will be L/min and L/min/m^2 for the indexed value.
|
Baseline
|
|
Pulmonary artery pressure
Time Frame: Baseline
|
The primary outcome will be to compare the estimated values using echocardiographic parameters with the same invasive measurement by right heart catheterization recorded on the same day to avoid different cardiac load conditions.
Right heart catheterization will be from either femural or jugular vein approach.
The measure's unit will be in mmHg, and it will be expressed as systolic, mean and diastolic pulmonary pressure.
|
Baseline
|
|
Pulmonary vascular resistance
Time Frame: Baseline
|
The primary outcome will be to compare the estimated values using echocardiographic parameters with the same invasive measurement by right heart catheterization recorded on the same day to avoid different cardiac load conditions.
Right heart catheterization will be from either femural or jugular vein approach.
The measure's unit will be in Woods Units
|
Baseline
|
|
Right atrial pressure
Time Frame: Baseline
|
The primary outcome will be to compare the estimated values using echocardiographic parameters with the same invasive measurement by right heart catheterization recorded on the same day to avoid different cardiac load conditions.
Right heart catheterization will be from either femural or jugular vein approach.
The measure's unit will be in mmHg.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
February 22, 2025
First Submitted That Met QC Criteria
February 27, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 17, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- TECH-HSR-2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.